Citation Impact
Citing Papers
Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice
2003
Drug Resistance and Pseudoresistance
2012
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
2020 Standout
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
2016
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate
2002
Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects
2003
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
Platelet Aggregation and Recruitment with Aspirin-Clopidogrel Therapy
2008
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction
2004 StandoutNobel
Perioperative Management of Antithrombotic Therapy
2012 Standout
The metabolic syndrome
2010 Standout
Platelet-Active Drugs
1998
Retinoic Acid Induced Suicidal Erythrocyte Death
2008
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review
2006 Standout
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Role of red blood cells in thrombosis
1999
Heterologous cell–cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)
2003
Platelet Activation and Atherothrombosis
2007 Standout
The metabolic syndrome
2005 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Antiplatelet Drugs
2008
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease
2003 Standout
Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)—its relation to metabolic control
2004
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
Update on Myocarditis
2012 Standout
Prevention of Venous Thromboembolism
2008 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers
2008
Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly
2004
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
2005
Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors
2013 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Diagnostic Performance of Cardiovascular Magnetic Resonance in Patients With Suspected Acute Myocarditis
2005
Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus
2004
Stimulation of Suicidal Erythrocyte Death by Methylglyoxal
2006
Myocarditis
2009 Standout
Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure
2005
N‐terminal probrain natriuretic peptide (NT‐proBNP) in the emergency diagnosis and in‐hospital monitoring of patients with dyspnoea and ventricular dysfunction
2004
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Myocarditis
2006 Standout
Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías
2000
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Control of Autoimmune Myocarditis and Multiorgan Inflammation by Glucocorticoid-Induced TNF Receptor Family-Related Proteinhigh, Foxp3-Expressing CD25+ and CD25− Regulatory T Cells
2006 StandoutNobel
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Deformation of light xenon isotopes
1995
Aspirin Resistance and Atherothrombotic Disease
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Differentiation Between Patients With Takotsubo Cardiomyopathy and Those With Anterior Acute Myocardial Infarction
2004
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
TRANSITION PROBABILITY FROM THE GROUND TO THE FIRST-EXCITED 2+ STATE OF EVEN–EVEN NUCLIDES
2001 Standout
Hereditary Deficiency of Protein C or Protein S Confers Increased Risk of Arterial Thromboembolic Events at a Young Age
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Works of A. Osa being referenced
Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy
1999
Thrombin‐activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system
2003
Resultados a largo plazo de la valvuloplastia mitral percutánea
1998
Utility of cardiac magnetic resonance imaging for the diagnosis of heart transplant rejection
2003
Utilidad del electrocardiograma para predecir el lugar de la oclusión en el infarto agudo de miocardio anterior con enfermedad aislada de la arteria descendente anterior
2002
Variables predictoras de mortalidad precoz tras el trasplante cardíaco ortotópico en adultos
1997
Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions
2006
Evolución de la insuficiencia mitral severa posvalvuloplastia
1999
Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca
2002
Lifetime measurement of the first2 + Ba 1 2 2 , 1 2 4 , 1 2 6
1992
Erythrocyte Promotion of Platelet Reactivity Decreases the Effectiveness of Aspirin as an Antithrombotic Therapeutic Modality
1998
Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.
2006